Nanobiotix S.A. (NASDAQ:NBTX) Short Interest Down 68.6% in January

Nanobiotix S.A. (NASDAQ:NBTX) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 22,300 shares, a decrease of 68.6% from the December 31st total of 71,100 shares. Based on an average daily volume of 29,900 shares, the days-to-cover ratio is currently 0.7 days.

Nanobiotix Price Performance

Shares of NASDAQ NBTX traded down $0.06 during trading hours on Tuesday, hitting $3.37. 5,348 shares of the company’s stock were exchanged, compared to its average volume of 23,726. The company’s 50-day moving average price is $3.17 and its 200-day moving average price is $4.34. Nanobiotix has a 1-year low of $2.76 and a 1-year high of $8.43.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.